BioTelemetry (BEAT) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil rises as Trump repeats Iran attack threat
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results
November 5, 2019 4:06 PM ESTExceeds ExpectationsDelivers Double Digit Revenue Growth
MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2019.
Quarter Highlights Â
Recognized quarterly revenue of $111.3 millionReached 11.3% year-over-year revenue growthAchieved 29th consecutive quarter of year-over-year revenue growthReported GAAP net income of $8.3 millionRealized quarterly adjusted EBITDA of... More